Postdoc start-up grant: First in vivo testing of novel CD40-TRAF6 inhibitors to treat atherosclerosis
| Institution | Klinikum der Ludwig-Maximilians-Universität München |
|---|---|
| Project leader | Venetia Bazioti |
| Site | München |
| Project type | Exzellenzprogramm |
| Funding | € 85.000,00 |
| Begin | 01.06.2026 |
| End | 31.05.2028 |
Förderkennzeichen
81X3600241
Projektnummer
2123